
New method allows tracking of HIV
According to study leaders Prof. Christian Eggeling from Leibniz IPHT, Dr. Cyril Favard and Dr. Delphine Muriaux from the Montpellier Infectious...

Versantis raises CHF16m in Series B financing
The CHF16m Series B financing was led by Swisscanto Invest by Zürcher Kantonalbank with co-financing by Esperante Venture, investiere, Redalpine...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan...

4SC expands domatinostat combo testing
In an investigator-initiated Phase Ib study (DONIMI) at NKI, 40 patients with melanoma will be enrolled before surgery (neoadjuvant setting) to...

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

AMR: GARDP and Entasis Therapeutics start pivotal study
In the open-label study enroling 1,000 patients, safety and efficacy of zoliflodacin will be compared with a combination of azithromycin and...